Proportion of isolates with decreased susceptibility or resistance in Latvia

Latvia: Proportion of isolates with decreased susceptibility or resistance was 0 in 2018. ◆ Volatile

Latest (2018)
0
World rank
15th
of 27 countries
All-time high
2.63
in 2013
All-time low
0
in 2009
Years of data
10
2009–2018

Proportion of isolates with decreased susceptibility or resistance in Latvia, 2009–2018

01232009201320182009: 02010: 02011: 02012: 2.62013: 2.62014: 02015: 02016: 02017: 02018: 0

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for proportion of isolates with decreased susceptibility or resistance in Latvia is 0, measured in 2018. That is the lowest value across all 10 years on record.

The figure is down 100.0% over five years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in Latvia peaked at 2.63 in 2013 and was at its lowest, 0, in 2009.

Latvia ranks 15th of 27 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in Latvia, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP in Latvia, 2009 to 2018.
Year Value Change
2009 0
2010 0
2011 0
2012 2.56
2013 2.63 +2.6%
2014 0 -100.0%
2015 0
2016 0
2017 0
2018 0

Averages by decade

DecadeAverage LowestHighest Years
2000s 0 0 0 1
2010s 0.5773 0 2.63 9

Countries ranked near Latvia

  1. 12 Germany 1 compare
  2. 13 Canada 0.5445 compare
  3. 14 United States of America 0.2907 compare
  4. 15 Estonia 0
  5. 15 Malta 0 compare
  6. 15 France 0 compare
  7. 15 Netherlands 0 compare
  8. 15 Slovakia 0 compare
  9. 15 Slovenia 0 compare
  10. 15 Iceland 0
  11. 15 Portugal 0 compare
  12. 15 Ireland 0 compare
  13. 15 Norway 0 compare
  14. 15 Côte d'Ivoire 0
  15. 15 Denmark 0 compare

See the full ranking of 27 places →

More health data for Latvia

All data for Latvia →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in Latvia?
Proportion of isolates with decreased susceptibility or resistance in Latvia was 0 in 2018, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Latvia?
The highest recorded value was 2.63 in 2013.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Latvia?
The lowest recorded value was 0 in 2009.
How does Latvia rank for proportion of isolates with decreased susceptibility or resistance?
Latvia ranks 15th out of 27 countries with data for 2018.
Where does this Latvia data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in Latvia. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 09 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-cefixime/latvia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-cefixime/latvia/">Proportion of isolates with decreased susceptibility or resistance in Latvia</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
27 places, 246 data points, 2009–2018
Last refreshed